昊海生科(688366.SH):全資子公司獲豬纖維蛋白粘合劑藥品註冊證書
格隆匯4月1日丨昊海生科(688366.SH)公佈,近日,公司全資子公司上海利康瑞生物工程有限公司(“上海利康瑞”)收到國家藥品監督管理局核准簽發的關於豬纖維蛋白粘合劑的《藥品註冊證書》。
豬纖維蛋白粘合劑是一種從豬血中提取蛋白質所製成的新型生物材料,主要有效成分為豬纖維蛋白原和豬凝血酶,具有減少出血、閉合創口、促進創傷癒合等作用,可廣泛輔助應用於常規手術操作控制出血不滿意的外科止血。
於臨牀手術中,採用縫線或縫訂進行傷口止血和組織重建後,應用豬纖維蛋白粘合劑能夠讓傷口迅速閉合、快速止血,亦可防止手術期間和手術後的氣體、血液和組織液的滲漏,且無需術後移除。在一些位置隱蔽、操作空間狹小的組織部位,豬纖維蛋白粘合劑操作簡便、安全高效。
此外,上海利康瑞擁有多項血漿採集技術的相關專利,於旗下生豬養殖基地進行活體採集,確保養殖環境、血漿來源更為可控,生產工藝更為穩定,提高產品安全性。同時,活體採漿技術亦可以實現循環採集、提高供體利用率,降低環境污染。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.